Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 10  •  04:00PM ET
10.45
Dollar change
0.00
Percentage change
0.00
%
Index- P/E75.62 EPS (ttm)0.14 Insider Own21.26% Shs Outstand17.25M Perf Week-0.10%
Market Cap228.93M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float17.25M Perf Month1.06%
Enterprise Value228.89M PEG- EPS next Q- Inst Own67.72% Short Float0.01% Perf Quarter2.65%
Income3.04M P/S- EPS this Y- Inst Trans- Short Ratio0.04 Perf Half Y-
Sales0.00M P/B1.33 EPS next Y- ROA- Short Interest0.00M Perf YTD4.40%
Book/sh7.84 P/C5723.25 EPS next 5Y- ROE- 52W High10.46 -0.10% Perf Year-
Cash/sh0.00 P/FCF- EPS past 3/5Y-13.14% - ROIC1.77% 52W Low10.00 4.50% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility0.23% 0.19% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)0.02 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.55 Sales Y/Y TTM- Profit Margin- RSI (14)67.42 Recom-
Dividend Gr. 3/5Y- - Current Ratio0.55 EPS Q/Q391.73% SMA200.42% Beta- Target Price-
Payout- Debt/Eq0.00 Sales Q/Q- SMA500.90% Rel Volume0.01 Prev Close10.45
Employees2 LT Debt/Eq0.00 Earnings- SMA2002.33% Avg Volume37.60K Price10.45
IPOFeb 13, 2025 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume545 Change0.00%
Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.